1. Home
  2. VBIV

as 07-26-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

VBI Vaccines Inc is a commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.

Founded: N/A Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 22.6M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 197.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -5.65 EPS Growth: N/A
52 Week Low/High: $0.45 - $1.36 Next Earning Date: 08-12-2024
Revenue: $9,411,000 Revenue Growth: 553.09%
Revenue Growth (this year): 50.9% Revenue Growth (next year): 165.67%

VBIV Daily Stock ML Predictions

Share on Social Networks: